Suchergebnisse - "biological therapy"

PubPharm (175)

1

Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry

enthalten in: Modern rheumatology | 2024

von Karakaş, A. | Gulle, S. | Can, G. | +17

2

Association between disease-modifying antirheumatic drugs for rheumatoid arthritis and risk of incident dementia : a systematic review with meta-analysis

enthalten in: RMD open | 2024

von Xie, W. | Hou, Y. | Xiao, S. | +2

3

Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis : a multicentre and retrospective study

enthalten in: RMD open | 2024

von López-Medina, C. | Calvo-Gutiérrez, J. | Ábalos-Aguilera, M. | +16

4

Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis : a network meta-analysis

enthalten in: RMD open | 2024

von Mease, P. | Reddy, S. | Ross, S. | +6

5

Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease : A Systematic Review and Meta-Analysis

enthalten in: Annals of family medicine | 2024

von Ebell, M. | Barry, H. | Baduni, K. | +1

6

Early identification of golimumab-treated patients with higher likelihood of long-term retention

enthalten in: Frontiers in immunology | 2024

von García-Dorta, A. | González-Dávila, E. | Sánchez-Jareño, M. | +5

7

Role of ustekinumab in treatment of ulcerative colitis : a narrative review

enthalten in: Immunotherapy | 2023

von Grova, M. | Vitello, A. | Mannino, M. | +4

8

Translated article] Consensus recommendations on the preventive treatment of migraine

enthalten in: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria | 2023

von Calleja-Hernández, M. | Guerrero-Peral, �. | Irimia-Sieira, P. | +5

9

Consensus recommendations for the treatment of migraine prevention

enthalten in: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria | 2023

von Calleja-Hernández, M. | Guerrero-Peral, �. | Irimia-Sieira, P. | +5

10

Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis : 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study

enthalten in: Annals of the rheumatic diseases | 2023

von Ritchlin, C. | Coates, L. | McInnes, I. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]